
|Articles|April 7, 2014
UBC Named Preferred Oncology Research Partner
United BioSource Corp. has been named the preferred oncology research partner by RainTree Oncology Services Corp
Advertisement
United BioSource Corp. (UBC) has been named the preferred oncology research partner by RainTree Oncology Services Corp., a community oncology alliance. The alliance seeks to standardize research processes within the the RainTree community oncology setting, UBC will have access to patient data and will partner to administer prospective and retrospective observation studies, which will provide information about the safety and efficacy of medicine in daily clinical use. UBC is a subsidiary of Express Scripts.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Real-Time Clinical Trials: What the FDA's Push Toward Continuous Oversight Means for Sponsors
2
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
3
ACT Brief: DIA Leadership and Infrastructure Priorities, Real-Time Data Review Readiness, and CLL Treatment Expansion
4
Built-In, Not Bolted On: Why Clinical Data Security Has to Be a Design Principle
5




